Articles tagged with Macrophages
Scientists have found that macrophages invade the diabetic pancreas, producing cytokines that contribute to insulin-producing beta cells' elimination. This discovery may lead to development of tailor-made anti-inflammatory therapies to reduce type 2 diabetes burden.
In a groundbreaking study, researchers found that benign E. coli bacteria can evolve to become pathogenic within 500 generations or 30 days when confronted with macrophages. The bacteria adapted by developing resistance to being killed by immune cells and acquiring traits similar to those of deadly pathogens.
VIB researchers have identified a protein, Nrp1, that suppresses the anti-tumor activity of macrophages. Blocking Nrp1 restores this immune response, leading to reduced tumor growth and improved prognosis.
Researchers have identified how golden staph bacteria target and destroy key immune cells, disrupting the body's defense against infection. By visualizing this process using advanced microscopy techniques, the team gained insights into how golden staph evades the immune system and causes tissue damage.
Researchers discovered that S. aureus converts neutrophil extracellular traps into a toxic molecule, dAdo, which kills macrophages and allows the bacteria to avoid immune destruction. The study provides new insights into the mechanisms behind S. aureus infections and offers potential therapeutic targets.
A dysfunctional chemokine receptor, CXCR1, plays a crucial role in Candida infection progression. Mice lacking this receptor are prone to kidney failure due to Candida-induced injury. Additionally, patients with a mutation in the CXCR1 gene are at higher risk of developing candidiasis.
Researchers from Imperial College London have discovered how Mycobacterium tuberculosis tricks the immune system to establish persistent infections. They hope to develop small molecule drugs that can block or destroy the bacteria by targeting these sugar molecules.
A new study from Japan found that individuals with a history of kidney stones have significantly increased levels of inflammatory chemokines GRO and CXCL1, while those without kidney stones have higher levels of anti-inflammatory cytokine IL-4. This research may lead to the development of new therapeutic drugs for kidney stone formation.
Researchers at the University of Washington have developed a method to target and eliminate harmful macrophages that dampen the immune response to cancer. By depleting these 'traitor' immune cells, tumor growth is slowed and survival rates are improved in mice with cancer.
The researcher aims to establish permanently growing, alternatively activated M2 macrophage cell lines to reduce animal use in studies. This innovation could provide scientists with almost limitless cells for study without the need for live mice.
Salmonella bacteria can manipulate macrophages to switch from an inflammatory to anti-inflammatory state, promoting chronic asymptomatic carriage of typhoid fever. This mechanism could lead to new treatments for typhoid fever, a disease that causes hundreds of thousands of deaths each year.
Researchers at Massachusetts General Hospital found that macrophage proliferation within plaques drives the growth of atherosclerotic lesions. This challenges the previous assumption that monocytes are solely responsible for plaque development.
A new study from the University of Toronto and Massachusetts General Hospital found that macrophage growth inside arterial plaques is not reliant on external cells. This discovery may lead to alternative approaches to treating atherosclerosis, a leading cause of cardiovascular disease.
Researchers at Caltech have discovered a new mechanism for creating macrophages by increasing the accumulation of regulatory protein PU.1 through slowed cell division. The process involves an unexpected cycle where cell division slows, allowing higher PU.1 levels to accumulate and prompt macrophage generation.
Researchers found that macrophages help regulate corpus luteum development during embryo implantation, which is essential for successful pregnancy. The absence of macrophages can lead to infertility due to disrupted hormone levels, but restoring them or administering hormones can correct this issue.
Macrophages are essential for producing progesterone, a crucial hormone for embryo implantation. Insufficient macrophages lead to poor embryo implantation and miscarriage. Treatment with progesterone can reverse the effects of reduced macrophage levels.
Researchers found that macrophages are essential for embryo implantation in the uterus. The absence of these cells leads to reduced hormone levels, causing embryos to fail to implant. Restoration of macrophage function or hormone replacement therapy can revive pregnancy, shedding new light on a potential cause of infertility.
Researchers found that DHA is converted into maresin 1 (MaR1), which inhibits inflammation and shifts macrophage phenotype, providing a potential lead for new drugs to treat chronic inflammation.
Researchers have discovered that genetically engineered immune cells can promote healing in mice infected with a neurological disease similar to multiple sclerosis. The new finding suggests that immune cells could be engineered to create a new treatment for people with MS.
Researchers at Temple University School of Medicine found that synthetic anti-inflammatory substances related to marijuana's active ingredient can attenuate HIV replication in macrophages. This discovery could lead to new drug therapies for HIV/AIDS, leveraging the human immune system's natural defenses.
Researchers found that stimulating the CB2 receptor in white blood cells weakens HIV-1 infection. Synthetic compounds may make current therapies more effective and provide protection against certain complications. The discovery holds promise for fighting other viral diseases.
Researchers found that excess tumor necrosis factor production initially kills TB pathogens, but later encourages their growth. Certain drug combinations can reverse this effect, potentially reverting hypersusceptibility to hyperresistance.
A study published in Cell Metabolism suggests that targeting cholesterol metabolism in the eye may prevent severe age-related macular degeneration. Researchers found that macrophages play a key role in clearing cholesterol from the eye, and that with aging, these cells become less efficient at this task.
Researchers found that age-related macular degeneration shares a common link with atherosclerosis due to impaired cholesterol efflux in macrophages. The study suggests that cholesterol-lowering eye drops or other medications could prevent vision loss caused by macular degeneration.
Two studies by Weill Cornell Medicine researchers propose new treatments for beta-thalassemia, HFE-related hemochromatosis, and polycythemia vera. The discovery reveals a crucial role of macrophages in regulating iron production and red blood cell production, offering new avenues for therapy.
A team of medical researchers has identified a specific microRNA, miR-342-5p, that plays a key role in promoting inflammation in atherosclerosis. Inhibiting this microRNA has been shown to retard the progression of the disease in animal models.
Researchers have found that macrophages help produce and eliminate red blood cells, which could lead to novel therapies for diseases affecting red blood cell balance. The study also showed that eliminating certain macrophages can normalize abnormal red blood cell counts in conditions like polycythemia vera.
A potentially lethal fungal infection can anticipate and disarm the host's immune attack by sequestering copper, shutting down copper pumps in macrophages. This study opens new options for drug development to target the fungus's detoxification machinery.
Penn researchers create a protein 'passport' that allows nanoparticles to bypass the immune system, facilitating targeted drug delivery and implant device functionality. The innovative approach could improve treatment efficacy by reducing inflammation and prolonging nanoparticle retention.
Researchers found that vitamin D3 and omega-3 fatty acids improved the immune system's ability to clear amyloid plaques from the brain. The study identified key genes and signaling networks regulated by these substances, which may help control inflammation and improve plaque clearance.
Researchers discovered a signaling pathway in macrophages that detects escaping bacteria and activates an enzyme to trigger self-destruction, protecting against lethal infections. The caspase-11 detection pathway protects mice from infection with Burkholderia species, including the potentially deadly B. pseudomallei.
A new study published in The American Journal of Pathology found that topical application of simvastatin significantly accelerates wound healing in diabetic mice by increasing angiogenesis and lymphangiogenesis. This is attributed to the increased number of infiltrating macrophages producing VEGF-C, suggesting a simple strategy with po...
Researchers at Scripps Research Institute have discovered new selective inhibitors of diacylglycerol lipases (DAGL), enzymes involved in making 2-AG, a key cannabinoid. Early tests suggest these compounds may also reduce pro-inflammatory molecules linked to rheumatoid arthritis, potentially leading to new therapeutic approaches.
A recent study has revealed the existence of a rare sub-group of activated immune cells that act as bodyguards to protect stem cells from premature differentiation. These macrophage cells secrete prostaglandins, which delay differentiation and preserve the youthful state of the stem cells.
A study published in The Journal of Cell Biology identifies a motor protein that helps HIV replicate in macrophages. KIF3A drives the virus along microtubules, facilitating its release from these cells. Inhibiting KIF3A may provide a new strategy for combating HIV.
Scientists at the University of Maryland School of Medicine created a stem cell model for Gaucher disease, allowing them to test potential therapies in a dish. The study uses genetically similar stem cells that react to drugs like patient cells, accelerating drug discovery and bringing hope to patients.
Researchers found that high-saturated fat diets increase endothelial lipase levels, associated with atherosclerosis, while omega-3 polyunsaturated fats lower these levels. This discovery may help explain why certain diabetes drugs raise heart risks and provides a new link between diet and cardiovascular disease.
Researchers discovered that influencing macrophage cells after injury can increase nerve regeneration rates by up to 20 times. The technique uses interleukin-4 cytokine to convert macrophages into a 'pro-healing' phenotype, promoting natural repair mechanisms.
Research reveals that activated macrophages accumulate triglycerides to support their function, leading to increased pathogen destruction. This finding provides new insights into the development of atherosclerosis and potential approaches to slowing its progression.
Researchers have upended assumptions on how high cholesterol leads to inflammation and atherosclerosis. Desmosterol, a precursor to cholesterol, has been found to suppress inflammatory response genes and regulate cholesterol balance.
A new study reveals the immune system and inflammation may play a significant role in Lou Gehrig's disease, specifically targeting motor neurons for clean-up by macrophages. Resolvin D1, an omega-3 fatty acid derivative, was found to curb inflammation and block harmful proteins, offering a potential new approach to treating ALS.
Researchers discovered that the Notch pathway contributes to the development of rheumatoid arthritis by influencing the differentiation and function of inflammatory macrophages. The study also shows that drugs under development for cancer could potentially be used to treat RA.
Researchers used video microscopy and mathematical modelling to challenge common assumptions about Salmonella infection. They found that macrophage infection rates are lower than previously thought, but infected cells can still be reinfected by other bacteria.
Activated CD14+Trem-1+iNOS+ intestinal macrophages increase NO production, leading to enhanced intestinal permeability and bacterial product translocation. This upregulation contributes to the development of decompensated liver cirrhosis.
A new study published in Nature has disproved the theory that pigeons' navigation skills are linked to iron-rich nerve cells in their beaks. Macrophages, specialized white blood cells, were found to contain tiny balls of iron instead, contradicting earlier research.
Researchers discovered that macrophages produce hydrogen peroxide, which activates the temperature sensor TRPM2 at normal body temperature. This mechanism enhances phagocytic activity and may lead to new treatment strategies for infection.
A major study published in the Journal of Clinical Investigation has identified a method to stop bladder cancer from metastasizing to the lungs. The study found that adding the protein RhoGDI2 to tumors reduces versican production, blocking the ability of cancer cells to grow in the lungs.
Researchers discovered that vitamin D3 activates key genes and cellular signaling networks to stimulate the immune system to clear amyloid-beta protein from the brain. The study provides new insights into the potential therapeutic benefits of vitamin D3 for Alzheimer's disease treatment.
Researchers found an enzyme called IDO helps clear cellular debris and promote tolerance to the body's own proteins and DNA. Blocking IDO can trigger autoimmune diseases like lupus in genetically programmed mice.
Researchers have discovered that toxins released by diseased brain cells trigger a vicious circle of immune system activation, leading to high levels of free radicals that attack healthy nerve cells. The discovery may lead to targeted therapies to slow down these diseases.
A team of researchers has discovered how the protein SAMHD1 protects immune cells from HIV by starving the virus of necessary building blocks. This finding could lead to more effective anti-HIV drugs and new insights into other viral infections.
Monocytes are extremely sensitive to reactive oxygen species (ROS), while macrophages and dendritic cells derived from monocytes are resistant due to their defective DNA repair mechanisms. This sensitivity may play a role in regulating the immune response and preventing excessive ROS production.
Five scientists have been awarded $2.25 million to develop innovative approaches to fighting cancer, including targeting macrophages and biomarkers. The grants aim to improve the prevention, diagnosis, and treatment of cancer.
Researchers found that vitamin D reduces inflammation and debris buildup in mouse eyes, improving vision. Vitamin D also triggers macrophages to change configuration, reducing damage and promoting clear vision. The study suggests a potential simple way to prevent age-related macular degeneration.
A new study by NYU Langone Medical Center researchers identified netrin-1 as a molecule that blocks the normal migration of macrophages out of arteries, causing them to accumulate and promote atherosclerosis. Genetically deleting netrin-1 can minimize atherosclerosis, reduce macrophage levels in plaque, and promote macrophage migration.
A team of researchers at UCSF has discovered that tiny immune cells called macrophages can switch on the brown fat in response to cold temperatures, inducing it to burn energy and produce heat. This finding suggests that the immune system plays a role in thermoregulation, potentially leading to new strategies for enhancing metabolism.
Hepcidin, a hormone that regulates iron levels, may be targeted to treat atherosclerosis. Suppressing hepcidin reduces iron levels in white blood cells, promoting reverse cholesterol transport and interfering with atherosclerosis progression.
Researchers have identified a type of immune cell, dendritic cells, that plays a protective role in atherosclerosis. The study found that classical dendritic cells help prevent the disease from progressing.
Researchers at Dalhousie University have discovered that a specific protein, S100A10, enables macrophages to break down tissue barriers and enter the tumor site, facilitating cancer cell growth and metastasis. This finding presents a potential target for blocking tumor growth by inhibiting S100A10 activity.
Researchers at Brigham and Women's Hospital have demonstrated the direct participation of IgE in atherogenesis in a mouse model. IgE stimulates macrophage and vascular smooth muscle cell apoptosis, leading to increased atherosclerotic lesions. Anti-IgE monoclonal antibodies may become a novel therapy for atherosclerosis.